News

The University of Newcastle Central Coast Clinical School and Central Coast Research Institute was officially opened today by the Hon Scott Morrison MP, Prime Minister of Australia.

The MedRad Forum was held in March 2022 at the The Global Centre for Research and Training in Radiation Oncology, University of Newcastle.

A team of researchers from the University of Newcastle have been awarded $468,000 as part of the Black Summer Bushfire Recovery Grant to assist communities in recovery and resilience in the wake of the 2019-20 fires.

The NSW New England region has one of the highest rates of heart disease in the state.

The culture of kindness will take centre stage on 9 March when the University of Newcastle rallies the support of its communities for its inaugural Gifting Day.

Cardiologist and researcher, Professor Andrew Boyle, will investigate whether a novel well-being app can reduce depression in patients discharged from hospital with acute heart failure.

The University of Newcastle’s Associate Professor Amanda Dawson is the first recipient of the prestigious Royal Australasian College of Surgeons NSW Women in Surgery Leadership award.

Researchers will investigate how the creative arts can support healthy brains and heathy minds as we age.

The University of Newcastle’s Professor Frances Kay-Lambkin is the new Chair of the National Health and Medical Research Council’s (NHMRC) Women in Health Science Committee.

Shane Darwin is the CEO of JBHXR, a startup which integrates virtual reality tech with training to significantly enhance the learner experience. Being at the forefront of the VR learning industry, Shane implements experiential learning/immersive learning technology to support a range of educators.

University Newcastle PhD student Dr Jayson Jeganathan will investigate the negative symptoms of psychosis after he was awarded a National Health and Medical Research Council (NHMRC) 2021 Postgraduate Scholarship.

University of Newcastle respiratory disease expert Professor Peter Wark will lead a new $2.1m project to develop targeted treatments for the rare genetic and life-threatening disease cystic fibrosis, which damages the lungs and digestive system.